293 related articles for article (PubMed ID: 14655195)
1. Cost analysis of renal replacement therapies in Finland.
Salonen T; Reina T; Oksa H; Sintonen H; Pasternack A
Am J Kidney Dis; 2003 Dec; 42(6):1228-38. PubMed ID: 14655195
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of the treatment of end-stage renal disease in Brazil.
Sesso R; Eisenberg JM; Stabile C; Draibe S; Ajzen H; Ramos O
Int J Technol Assess Health Care; 1990; 6(1):107-14. PubMed ID: 2113888
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
Yang F; Lau T; Luo N
Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
[TBL] [Abstract][Full Text] [Related]
4. Cost of renal replacement therapy in Turkey.
Erek E; Sever MS; Akoglu E; Sariyar M; Bozfakioglu S; Apaydin S; Ataman R; Sarsmaz N; Altiparmak MR; Seyahi N; Serdengecti K
Nephrology (Carlton); 2004 Feb; 9(1):33-8. PubMed ID: 14996307
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.
Portolés J; Moreno F; López-Sánchez P; Mancha J; Gómez M; Corchete E; Del Peso G; Bajo MA; Llópez-Carratalá R; Fernández-Perpén A;
Nefrologia; 2011; 31(4):441-8. PubMed ID: 21738247
[TBL] [Abstract][Full Text] [Related]
6. End-stage renal care in developing countries: the India experience.
Jha V
Ren Fail; 2004 May; 26(3):201-8. PubMed ID: 15354966
[TBL] [Abstract][Full Text] [Related]
7. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
8. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
De Vecchi AF; Dratwa M; Wiedemann ME
Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
[TBL] [Abstract][Full Text] [Related]
9. Is CAPD a viable option among ADPKD with end stage renal disease population in India? Its outcomes and economics.
Kaul A; Dharshan R; Bhadhuaria D; Prasad N; Gupta A; Sharma RK
Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):906-11. PubMed ID: 26354561
[TBL] [Abstract][Full Text] [Related]
10. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
11. Alternative strategies to evaluate the cost-effectiveness of peritoneal dialysis and hemodialysis.
Salonen T; Reina T; Oksa H; Rissanen P; Pasternack A
Int Urol Nephrol; 2007; 39(1):289-98. PubMed ID: 17333524
[TBL] [Abstract][Full Text] [Related]
12. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
Zhang H; Zhang C; Zhu S; Ye H; Zhang D
BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
[TBL] [Abstract][Full Text] [Related]
13. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
[TBL] [Abstract][Full Text] [Related]
14. Cost utility analysis of end stage renal disease treatment in Ministry of Health dialysis centres, Malaysia: Hemodialysis versus continuous ambulatory peritoneal dialysis.
Surendra NK; Abdul Manaf MR; Hooi LS; Bavanandan S; Mohamad Nor FS; Firdaus Khan SS; Meng OL; Abdul Gafor AH
PLoS One; 2019; 14(10):e0218422. PubMed ID: 31644577
[TBL] [Abstract][Full Text] [Related]
15. Economics of dialysis and renal transplantation in the developing world.
Chugh KS; Jha V; Chugh S
Transplant Proc; 1999 Dec; 31(8):3275-7. PubMed ID: 10616473
[No Abstract] [Full Text] [Related]
16. Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data.
Mohnen SM; van Oosten MJM; Los J; Leegte MJH; Jager KJ; Hemmelder MH; Logtenberg SJJ; Stel VS; Hakkaart-van Roijen L; de Wit GA
PLoS One; 2019; 14(8):e0220800. PubMed ID: 31415578
[TBL] [Abstract][Full Text] [Related]
17. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
[TBL] [Abstract][Full Text] [Related]
18. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
[TBL] [Abstract][Full Text] [Related]
19. [Cost-effectiveness of interventions for end-stage renal disease].
Arredondo A; Rangel R; de Icaza E
Rev Saude Publica; 1998 Dec; 32(6):556-65. PubMed ID: 10349148
[TBL] [Abstract][Full Text] [Related]
20. Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis.
Rocha MJ; Ferreira S; Martins LS; Almeida M; Dias L; Pedroso S; Henriques AC; Almeida R; Cabrita A
Clin Transplant; 2012; 26(4):529-31. PubMed ID: 22211715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
